Reverberations for Ebos in Chemist Warehouse reverse listing

Reverberations for Ebos in Chemist Warehouse reverse listing
Sigma shareholders might well ask themselves if they're paying too much. (Image: NZME)
Paul McBeth
Discount pharmacist Chemist Warehouse’s reverse takeover of drugmaker Sigma Healthcare to build Australia’s biggest pharmacy group won’t immediately dent Ebos Group and may even offer some opportunities down the road. The discount pharmacist found its route onto the Australian securities exchange (ASX) via a reverse listing of Sigma, where Sigma will borrow A$1 billion (NZ$1.07b) from ANZ and National Australia Bank, give A$700m of that to the Chemist Warehouse shareholders and issue them shares equivalent to 85.8% of the...

More Markets

Neuren's 'embarrassment of opportunities'
Markets

Neuren's 'embarrassment of opportunities'

The pharmaceutical firm is pushing for approval of multiple phase-three trials in 2026.

Bremworth's Greg Smith’s next chapter
Primary Sector

Bremworth's Greg Smith’s next chapter

His exit was a consequence of the boardroom coup.

NZME's Chapman 'misleading' says Caniwi's Bowker
Markets

NZME's Chapman 'misleading' says Caniwi's Bowker

Troy Bowker says Barbara Chapman may not survive to make choices about the new chair.